Compositions and methods for the biosynthesis of 1,4-butanediol and its precursors
US-2015368676-A1 · Dec 24, 2015 · US
US11111496B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11111496-B2 |
| Application number | US-201816481799-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 30, 2018 |
| Priority date | Jan 30, 2017 |
| Publication date | Sep 7, 2021 |
| Grant date | Sep 7, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Genetically modified microorganisms that have the ability to convert carbon substrates into chemical products such as 2,3-BDO are disclosed. For example, genetically modified methanotrophs that are capable of generating 2,3-BDO at high titers from a methane source are disclosed. Methods of making these genetically modified microorganisms and methods of using them are also disclosed.
Opening claim text (preview).
What is claimed is: 1. A genetically modified microorganism capable of converting a Cl carbon to 2,3-BDO, wherein the microorganism is from the species Methylococcus capsulatus and comprises at least one heterologous gene encoding: i) an acetoin reductase; ii) an alpha-acetolactate decarboxylase; and/or iii) an acetolactate synthase. 2. The microorganism of claim 1 , comprising: (i) a heterologous acetoin reductase; (ii) a heterologous alpha-acetolactate decarboxylase; and/or (iii) a heterologous acetolactate synthase. 3. The microorganism of claim 2 , wherein the acetolactate synthase is non-constitutively expressed. 4. The microorganism of claim 2 , wherein: (i) the acetolactate synthase comprises an amino acid sequence that is at least 90% identical to SEQ ID NO: 1 or 19; (ii) the alpha-acetolactate decarboxylase comprises an amino acid sequence that is at least 90% identical to SEQ ID NO: 7; and/or (iii) the acetoin reductase comprises an amino acid sequence that is at least 90% identical to SEQ ID NO: 9. 5. The microorganism of claim 2 , wherein the acetoin reductase is NADPH-dependent. 6. The microorganism of claim 1 , wherein the heterologous gene(s) is/are integrated by an integration vector into the genome of said microorganism. 7. The microorganism of claim 1 , wherein the heterologous gene(s) is/are expressed on an episomal vector. 8. The microorganism of claim 1 comprising: (a) a heterologous gene encoding acetolactate synthase that is 5′ in relation to any other heterologous gene; (b) a heterologous gene encoding acetoin reductase that is 3′ in relation to any other heterologous gene; and/or (c) a heterologous gene encoding alpha-acetolactate decarboxylase that is neither 5′ or 3′ in relation to any other heterologous gene. 9. The microorganism of claim 1 , wherein the heterologous gene(s) is/are under the control of a switch. 10. The microorganism of claim 1 , wherein: (i) the acetolactate synthase comprises an amino acid sequence at least 90% identical to any one of SEQ ID NOs: 1, 3, or 19; (ii) the alpha-acetolactate decarboxylase comprises an amino acid sequence at least 90% identical to SEQ ID NO: 5 or 7; and/or (iii) the acetoin reductase comprises an amino acid sequence at least 90% identical to any one of SEQ ID NO: 9, 11, or 13. 11. A method of making the microorganism of claim 1 , the method comprising transforming the microorganism with a heterologous nucleic acid comprising a gene encoding an acetoin reductase, an alpha-acetolactate decarboxylase, and/or an acetolactate synthase. 12. A method of making 2,3-BDO, the method comprising: a) contacting the microorganism of claim 1 with a Cl carbon; and b) growing the microorganism to produce 2,3-BDO. 13. The method of claim 12 , wherein the Cl carbon is methane. 14. The method of claim 12 , wherein the microorganism is grown at a temperature between 32° C. and 49° C. 15. The method of claim 12 , further comprising contacting the microorganism with media containing at least 1 μM lanthanum before growing the microorganism to produce 2,3-BDO. 16. The method of claim 15 , further comprising diluting the lanthanum in media before growing the microorganism to produce 2,3-BDO. 17. The method of claim 12 , wherein the microorganism comprises a heterologous gene encoding alpha-acetolactate decarboxylase and is grown to produce acetoin. 18. The method of claim 12 , further comprising contacting the 2,3-BDO with a catalyst to produce butadiene or methyl ethyl ketone.
Related publications grouped by family.
Answers are generated from the same data shown on this page.